Multiple hypertension guidelines have been published in the last 10years, but the Kidney Disease: Improving Global Outcomes (KDIGO) and American Society of Transplantation (AST) guidelines are the only to recommended a target blood pressure in kidney transplant recipients. In this manuscript, we will...
End-Stage Renal Disease (ESRD) or Amyotrophic Lateral Sclerosis (ALS): Individuals with ESRD (permanent kidney failure requiring dialysis or a kidney transplant) or ALS (Lou Gehrig’s disease) are eligible for Medicare, including Part B, regardless of age. Understanding when and how to apply fo...
Supplemental Digital Content is Available in the Text.#Persons with HIV (PWH) with end-stage kidney disease (ESKD) who are eligible for kidney transplantat... C Mayer,SE Agbobli-Nuwoaty,J Li,... - 《Jaids Journal of Acquired Immune Deficiency Syndromes》 被引量: 0发表: 2024年 Training...
16.Barratt J, Rovin B, Zhang H, et al. POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS. Kidney Int Rep. 2022;7(2):S...
16.Barratt J, Rovin B, Zhang H, et al. POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS. Kidney Int Rep. 2022;7(2):S236. doi:10.1016/j.ekir.2022.01.577 ...
#3.The transplantation of vascularized human organ transplants, such as kidney, liver, heart, lung, or pancreas, is not subject to regulation by the FDA and is not FDA Approved. #4.Tobacco products are not approved by the FDA. #5.The FDA does not approve cosmetics except color additives...
#3. The transplantation of vascularized human organ transplants, such as kidney, liver, heart, lung, or pancreas, is not subject to regulation by the FDA and is not FDA Approved. #4. Tobacco products are not approved by the FDA. #5. The FDA does not approve cosmetics except color add...
a进行了雷公藤多甙干预慢性移植肾肾病进展的大鼠动物模型研究,为临床的应用找到了依据 Has conducted the big mouse animal model study which the Tripterygium wilfordii multi-glucoside intervention chronicity transplant kidney nephrosis progresses, had found the basis for the clinical application[translate] ...
Kidney Int. 2005, 67, 1830–1836. [Google Scholar] [CrossRef] Kazantzis, G. Cadmium, osteoporosis and calcium metabolism. Biometals 2004, 17, 493–498. [Google Scholar] [CrossRef] Pitt, M.A. Molybdenum toxicity: Interactions between copper, molybdenum and sulphate. Agents Actions 1976, 6,...
Acute kidney injury (AKI) can be caused by various factors such as toxins, ischemia, sepsis, obstructive uropathy, and others. Currently, there are two main classification systems that are used for determination of AKI severity in clinical practice, and these are the Risk/Injury/Failure/Loss/End...